BSBianca Gomes de Souza

Bianca Gomes de Souza

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bianca Gomes de Souza has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effects of the Supplementation of N-acetylcysteine on Redox Imbalance, Cytokine Levels, and Perinatal Outcomes in Pregnant Women with Preeclampsia: A Double-Blind, Randomized, Placebo-Controlled Pilot Study

    by Danielle Alice Vieira da Silva, Micaely Cristina dos Santos Tenório, Fabiana Andréa Moura, Nassib Bezerra Bueno, Nathálya da Silva Severino, Alexandra Rodrigues Bezerra, Bianca Gomes de Souza, Marilene Brandão Tenório Fragoso, Tauane Alves Dutra, Orlando Roberto Pimentel de Araújo, et al.

    Background/Objectives: This study aimed to evaluate the effects of oral administration of N-acetylcysteine (NAC) in pregnant women with preeclampsia (PE), using serum markers of redox imbalance and cytokine levels and perinatal outcomes. Methods: A double-blind, randomized, placebo-controlled pilot study was carried out from 2021 to 2023. The study was retrospectively registered with REBEC (Brazilian Clinical Trials Registry). After screening, women were randomized into 2 groups according to the type of supplementation: 600 mg of NAC (NAC group) or capsules containing 2% colloidal silicon dioxide and 98% microcrystalline cellulose (placebo group) until delivery. Blood samples were collected to quantify biomarkers of redox imbalance and cytokine levels. Questionnaires containing socioeconomic, clinical, obstetric, and anthropometric data were applied. Results: A total of 51 pregnant women with PE were included (26 in the placebo group and 25 in the NAC group). The use of NAC was associated with a higher gestational age at birth (GA) of the conceptus (placebo group: 37.39 weeks ± 1.96 SD vs. NAC group: 38.45 weeks ± 1.51 SD; p = 0.044). A moderate effect size was observed for this variable (Cohen’s d = 0.52). However, treatment allocation (NAC vs. control) was not independently associated with gestational age at birth after adjustment for covariates (F(1,28) = 0.144; p = 0.707; η2p = 0.005). The adjusted mean difference between groups was 0.92 weeks (95% CI: −0.16 to 2.00). No other significant effects on redox and inflammatory markers were identified using NAC. Conclusions: NAC supplementation did not impact the mode of delivery between the NAC and placebo groups. As a secondary exploratory finding, a possible trend toward prolonged gestational age was observed in the NAC group; however, this result should be interpreted with caution, given the exploratory nature of the analysis, the neutrality of the primary outcome, and the limited sample size.

  • Open Access

    Intestinal microbiota composition in pregnant women and its influence on the incidence of adverse perinatal outcomes

    by Thiago Marques Wanderley, Bianca Gomes de Gomes de Souza, Tauane Alves Dutra, Danielle Alice Vieira da Silva, Marilene Brandão Tenório Fragoso, Nassib Bezerra Bueno, Alane Cabral Menezes de Oliveira

    Objective: Investigating the association between intestinal microbiota composition in pregnant women and incidence of adverse perinatal outcomes based on a systematic review. Methods: The search was carried out in PubMed, Embase, Lilacs, Scopus and Web of Science databases. A formal protocol was registered in PROSPERO database (registration number CRD42023470580). The quality of the selected studies was assessed based on the Joanna Briggs Institute Reviewer Manual. Results: In total, 7.393 articles were identified after the search and twelve studies were selected for the present review. Sample size ranged from 16 to 1.479 women, and participants' chronological age ranged from 20 to 40 years old. For the analysis of intestinal microbiota, all articles used fecal samples, with genetic extraction of nucleic acids such as deoxyribonucleic acid and ribonucleic acid, and sequencing of specific genes from fecal. Eight different outcomes were identified, including fetal demise, fetal abdominal circumference, intrauterine growth, femoral length, weight, head circumference, premature birth and gestational weight gain. These outcomes were associated with more than thirty (30) intestinal strains, such as those from the families Eubacteriaceae, Lachnospiraceae, Ruminococcaceae, Parabacteroides, and the genus Streptococcus. Conclusion: This review highlighted the existence of an association between intestinal microbiota and adverse perinatal outcomes, such as fetal demise, fetal abdominal circumference, intrauterine growth, femoral length, weight, head circumference, and premature birth, with over thirty strains of intestinal bacteria.

  • Validation and reproducibility of a FFQ focused on pregnant women living in Northeastern Brazil

    by Micaely Cristina dos Santos Tenório, Thiago Marques Wanderley, Isadora Albuquerque Macedo, Alanna Lira Ataide Vanderlei, Bianca Gomes de Souza, Thays Ataide-Silva, Alane Cabral Menezes de Oliveira

    Objective: The aim of the current study is to assess the validity and reproducibility of a FFQ focused on pregnant women living in Northeastern Brazil.Design: Three 24-hour-dietary recalls (24 hR) and two FFQ were applied at 15-d intervals between research stages in order to confirm the validity and reproducibility of the FFQ. Validity assessment was based on Pearson’s correlation coefficient (PCC) or Spearman’s correlation coefficient (SCC) between FFQ and the mean of three 24 hR (the 24 hR was used as reference standard), whereas reproducibility assessment was based on the intraclass correlation coefficient (ICC) among FFQ, and P < 0·05 was set as significance level.Setting: Public health network of a capital city in Northeastern Brazil.Participants: Overall, 100 pregnant women were included in the study.Results: The PCC or SCC adopted in the validity analysis recorded the recommended values (from 0·4 and 0·7) for energy (0·44; P < 0·001), carbohydrate (0·40; P < 0·001), vitamins B2 (0·40; P < 0·001), B5 (0·40; P < 0·001), E (0·47; P < 0·001), B12 (0·48; P < 0·001), phosphorus (0·92; P < 0·001), Mg (0·81; P < 0·001), Se (0·70; P < 0·001), cholesterol (0·64; P < 0·001), saturated (0·76; P < 0·001), polyunsaturated (0·73; P < 0·001) and monounsaturated fats (0·87; P < 0·001) and fibres (0·77; P < 0·001). Mg (0·72; P < 0·001), Fe (0·65; P < 0·001), lipid (0·56; P < 0·001) and energy (0·55; P < 0·001) presented ICC within the recommended reproducibility values.Conclusions: The FFQ developed in the current study is a useful tool to assess the usual food intake of pregnant women.